Katarina Luptakova
2023
In 2023, Katarina Luptakova earned a total compensation of $932.2K as Chief Medical Officer at Xilio Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $156,240 |
|---|---|
| Option Awards | $340,253 |
| Salary | $421,667 |
| Other | $14,010 |
| Total | $932,170 |
Luptakova received $421.7K in salary, accounting for 45% of the total pay in 2023.
Luptakova also received $156.2K in non-equity incentive plan, $340.3K in option awards and $14K in other compensation.
Rankings
In 2023, Katarina Luptakova's compensation ranked 1,264th out of 2,878 executives tracked by ExecPay. In other words, Luptakova earned more than 56.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,264 out of 2,878 | 56th |
Division Manufacturing | 759 out of 1,582 | 52nd |
Major group Chemicals And Allied Products | 507 out of 891 | 43rd |
Industry group Drugs | 495 out of 854 | 42nd |
Industry Pharmaceutical Preparations | 343 out of 614 | 44th |
Source: SEC filing on April 25, 2024.
Luptakova's colleagues
We found three more compensation records of executives who worked with Katarina Luptakova at Xilio Therapeutics in 2023.